Gigoux, M, Zappasodi, R, Park, J J, Pourpe, S, Ghosh, A, Bozkus, C C, Mangarin, L M B, Redmond, D, Svena Verma, S, Sara Schad, S, Duke, W, Jan, M, Leventhal, M, Ho, V, Gabriela Hobbs, G, Knudsen, T A, Skov, V, Kjær, L, Larsen, T S, Lund Hansen, D, Lindsley, R C, Hasselbalch, H C, Grauslund, J, Andersen, M, Holmström, M, Chan, T, Rampal, R, Abdel-Wahab, O, Nina Bhardwaj, N, Wolchok, J D, Mullally, A & Merghoub, T 2020, ' MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination ', Journal for ImmunoTherapy of Cancer, vol. 8, no. Suppl. 3, 444 . https://doi.org/10.1136/jitc-2020-SITC2020.0444
Gigoux, M, Zappasodi, R, Park, J J, Pourpe, S, Ghosh, A, Bozkus, C C, Mangarin, L M B, Redmond, D, Svena Verma, S, Sara Schad, S, Duke, W, Leventhal, M, Jan, M, Ho, V, Hobbs, G, Knudsen, T A, Skov, V, Kjær, L, Larsen, T S, Lund Hansen, D, Coleman Lindsley, R, Hasselbalch, H C, Grauslund, J H, Mads H Andersen, M H, Holmström, M O, Chan, T, Rampal, R, Abdel-Wahab, O, Nina Bhardwaj, N, Wolchok, J D, Mullally, A & Merghoub, T 2020, ' Heteroclitic peptide cancer vaccine counters MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms ', Journal of Immunology, vol. 204, no. Suppl. 1, 239.34 . < https://www.jimmunol.org/content/204/1_Supplement/239.34 >